Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study

Abstract

Background

Using double inversion recovery (DIR) MRI, cortical lesions can be seen in the brain of patients with multiple sclerosis (MS). The burden of such lesions seems to be well correlated with the severity of MS-related disability.

Objective

To investigate whether the extent of cortical damage in patients with benign MS (BMS) might contribute to explain their favorable clinical status.

Methods

Forty-eight patients with BMS (Expanded Disability Status Scale [EDSS] score ≤3.0 and disease duration ≥15 years) and 96 patients with non-disabling, early relapsing–remitting (RR) MS (EDSS score ≤3.0 and disease duration ≤5 years) were studied. Brain MRI, including a DIR and a fluid-attenuated inversion recovery (FLAIR) sequence, was acquired at baseline and after 12 months. On DIR images, intracortical (ICL) and cortical-subcortical lesions (CSL) were identified and their number and volume calculated. Total white matter (WM) lesion volume was quantified on FLAIR images.

Results

Compared with early RRMS, patients with BMS had lower number of ICL at both study time points (P ≤ 0.001 for both comparisons). At one-year follow-up, a significant increase of ICL and CSL number and total volume was observed only in early patients with RRMS. The number and volume of cortical lesions was not correlated with WM lesion volume. Total ICL number at baseline, total cortical lesion volume at baseline, and total cortical lesion volume change were independent predictors of MS phenotype.

Conclusion

In patients with BMS, the selective sparing of the cortex from disease-related focal pathology might be one of the factors associated to their favorable clinical status, independently of the (possible) accrual of WM lesions.

Keywords

multiple sclerosis cortical lesions double inversion recovery sequence

Get full access to this article

View all access options for this article.

References

1 Noseworthy JH Lucchinetti C Rodriguez M Weinshenker BG . Multiple Sclerosis. N Engl J Med 2000; 343: 938–852 [Review].

2 Hawkins SA McDonnell GV . Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J Neurol Neurosurg Psychiatry 1999; 67: 148–152.

3 Ramsaransing GS De Keyser J . Benign course in multiple sclerosis: a review. Acta Neurol Scand 2006; 113: 359–369 [Review].

4 Lublin FD Reingold SC . Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996; 46: 907–911.

5 Ramsaransing G Maurits N Zwanikken C De KJ . Early prediction of a benign course of multiple sclerosis on clinical grounds: a systematic review. Mult Scler 2001; 7: 345–347.

6 Peterson JW Bo L Mork S Chang A Trapp BD . Transected neurites, apoptotic neurons and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50: 389–400.

7 Kidd D Barkhof F McConnel R Algra PR Allen IV Revesz T . Cortical lesions in multiple sclerosis. Brain 1999; 122: 17–26.

8 Bo L Vedeler CA Nyland HI Trapp BD Mork SJ . Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003; 62: 723–732.

9 Kutzelnigg A Lucchinetti CF Stadelmann C . Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705–2712.

10.

10 Dalton CM Chard DT Davies GR . Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004; 127: 1101–1107.

11.

11 Chard DT Griffin CM McLean MA . Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 2002; 125: 2342–2352.

12.

12 Calabrese M Atzori M Bernardi V . Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 2007; 254: 1212–1220.

13.

13 Chen JT Narayanan S Collins DL Smith SM Matthews PM Arnold DL . Relating neocortical pathology to disability progression in multiple sclerosis using MRI. NeuroImage 2004; 23: 1168–1175.

14.

14 Pagani E Rocca MA Gallo A . Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. AJNR Am J Neuroradiol 2005; 26: 341–346.

15.

15 Rovaris M Filippi M Minicucci L . Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. AJNR Am J Neuroradiol 2000; 21: 402–408.

16.

16 Portaccio E Amato MP Bartolozzi ML . Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment. J Neurol Sci 2006; 245: 195–199.

17.

17 Geurts JJ Bo L Pouwels PJ Castelijns JA Polman CH Barkhof F . Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. AJNR Am J Neuroradiol 2005; 26: 572–577.

18.

18 Geurts JJ Pouwels PJ Uitdehaag BM Polman CH Barkhof F Castelijns JA . Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 2005; 236: 254–260.

19.

19 Calabrese M De Stefano N Atzori M . Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch Neurol 2007; 64: 1416–1422.

20.

20 Kurtzke JF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444–1452.

21.

21 Poser CM Paty DW Scheinberg LC . New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227–231.

22.

22 Amato MP Portaccio E Goretti B . The Rao's Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population. Mult Scler 2006; 12: 787–793.

23.

23 Benjamini Y Hochberg Y . Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57: 289–300.

24.

24 Pittock SJ McClelland RL Mayr WT . Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Ann Neurol 2004; 56: 303–306.

25.

25 Sayao AL Devonshire V Tremlett H . Longitudinal follow-up of “benign” multiple sclerosis at 20 years. Neurology 2007; 68: 496–500.

26.

26 Rugg-Gunn FJ Boulby PA Symms MR Barker GJ Duncan JS . Imaging the neocortex in epilepsy with double inversion recovery imaging. Neuroimage 2006; 31: 39–50.

27.

27 Cotton F Rambaud L Hermier M . Dual inversion recovery MRI helps identifying cortical tubers in tuberous sclerosis. Epilepsia 2006; 47: 1072–1073.

28.

28 Nelson F Poonawalla AH Hou P Huang F Wolinsky JS Narayana PA . Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. AJNR Am J Neuroradiol 2007; 28: 1645–1649.

29.

29 De Stefano N Battaglini M Stromillo ML . Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. Brain 2006; 129: 2008–2016.

30.

30 Pirko I Lucchinetti CF Sriram S Bakshi R . Grey matter involvement in multiple sclerosis. Neurology 2007; 68: 634–642.

31.

31 Strasser-Fuchs S Enzinger C Ropele S Wallner M Fazekas F . Clinically benign multiple sclerosis despite large T2 lesion load: can we explain this paradox. Mult Scler 2008; 14: 205–211.

32.

32 Rovaris M Judica E Gallo A . Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain 2006; 129: 2628–2634.

33.

33 Agosta F Rovaris M Pagani E Sormani MP Comi G Filippi M . Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain 2006; 129: 2620–2627.

34.

34 Rocca MA Filippi M . Functional MRI to study brain plasticity in clinical neurology. Neurol Sci 2006; 27(Suppl. 1): S24–S26.

35.

35 Rocca MA Filippi M . Functional MRI in multiple sclerosis. J Neuroimaging 2007; 17(Suppl. 1): 36S–41S.

36.

36 Ceccarelli A Rocca MA Pagani E . The topographical distribution of tissue injury in benign MS: a 3T multiparametric MRI study. NeuroImage 2008; 39: 1499–1509.